Efficacy and safety of micafungin for the prophylaxis of invasive fungal infection during neutropenia in children and adolescents undergoing allogeneic hematopoietic SCT

Multicenter, Randomized, Open-Label Study Comparing the Efficacy and Safety of Micafungin versus Itraconazole for Prophylaxis of Invasive Fungal Infections in Patients undergoing Hematopoietic Stem Cell Transplant

(2012) Xiaojun Huang et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Safety, tolerance and outcome of treatment with liposomal amphotericin B in paediatric patients with cancer or undergoing haematopoietic stem cell transplantation

(2009) Hedwig Kolve et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Antifungal prophylaxis with micafungin in patients treated for childhood cancer

(2009) Shigenori Kusuki et al.   PEDIATRIC BLOOD & CANCER

Primary Antifungal Prophylaxis in Adult Hematopoietic Stem Cell Transplant Recipients: Current Therapeutic Concepts

(2009) Dorothy McCoy et al.   PHARMACOTHERAPY

The changing epidemiology of invasive candidiasis

(2008) Ray Hachem et al.   CANCER

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES

Use of micafungin versus fluconazole for antifungal prophylaxis in neutropenic patients receiving hematopoietic stem cell transplantation

(2008) Yasushi Hiramatsu et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY